Food and drugs administration warns against black marketing of Covid drugs in Nashik

NASHIK: The food and drugs administration (FDA) of Nashik has warned against black marketing of Remdesivir and Tocilizumab medicines required in Covid-19 treatment.
Joint commissioner of FDA Dushyant Bhamre has said that the stocks of both medicines were adequately available in the district and, hence, any attempts to overcharge for the same or selling them in the black market will not be tolerated under any circumstances.
Bhamre has also appealed to the people to dial 1800 2223 65 if they have any information about black marketing of these medicines.
He said that cabinet minister for food and drugs administration Rajendra Shingne had conducted a meeting of government officials and pharma manufacturers to get an idea of the stock of medicines across the state.
“The minister held a meeting with pharma companies who have assured that there was no dearth of medicines in the state and, hence, anybody found black marketing these medicines will be prosecuted,” the officer said. For Maharashtra, 21,500 vials of Remdesivir will be made available soon. Also, enought stock of Tocilizumab medicines will also be made available in appropriate quantity, said Bhamre.